Can Hypnotherapy Be Considered a Valuable Component in the Management of Inflammatory Bowel Disease? Insights from a Comprehensive Review

References

• Appleton, J. (2018). The gut-brain axis: Influence of microbiota on mood and mental health. Integrative Medicine (Encinitas, Calif.), 17(4), 28–32. PMID: 31043907.
   Google Scholar
• Ardizzone, S., Maconi, G., Russo, A., Imbesi, V., Colombo, E., & Bianchi Porro, G. (2006). Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut, 55(1), 47–53. https://doi.org/10.1136/gut.2005.068809
   PubMed Web of Science ®Google Scholar
• Bonaz, B. L., & Bernstein, C. N. (2013). Brain-gut interactions in inflammatory bowel disease. Adenocarcin Barrett’s Epithelium Gastroenterol, 144(1), 36–49. https://doi.org/10.1053/j.gastro.2012.10.003
   PubMed Web of Science ®Google Scholar
• Carabotti, M., Scirocco, A., Maselli, M. A., & Severi, C. (2015). The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology, 28(2), 203–209. PMID: 25830558.
   PubMed Web of Science ®Google Scholar
• Chiarello, M. M., Pepe, G., Fico, V., Bianchi, V., Tropeano, G., Altieri, G., & Brisinda, G. (2022). Therapeutic strategies in Crohn’s disease in an emergency surgical setting. World Journal of Gastroenterology, 28(18), 1902–1921. https://doi.org/10.3748/wjg.v28.i18.1902
   PubMed Web of Science ®Google Scholar
• Elhag, D. A., Kumar, M., Saadaoui, M., Akobeng, A. K., Al-Mudahka, F., Elawad, M., & Al Khodor, S. (2022). Inflammatory bowel disease treatments and predictive biomarkers of therapeutic response. International Journal of Molecular Sciences, 23(13), 6966. https://doi.org/10.3390/ijms23136966
   PubMed Web of Science ®Google Scholar
• Emami, M. H., Gholamrezaei, A., & Daneshgar, H. (2009). Hypnotherapy as an adjuvant for the management of inflammatory bowel disease: A case report. The American Journal of Clinical Hypnosis, 51(3), 255–262. https://doi.org/10.1080/00029157.2009.10401675
   PubMed Web of Science ®Google Scholar
• Farrokhyar, F., Marshall, J. K., Easterbrook, B., & Irvine, E. J. (2006). Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: Prevalence and impact on health. Inflammatory Bowel Diseases, 12(1), 38–46. https://doi.org/10.1097/01.mib.0000195391.49762.89
   PubMed Web of Science ®Google Scholar
• Flik, C. E., Laan, W., Zuithoff, N. P. A., van Rood, Y. R., Smout, A. J. P. M., Weusten, B. L. A. M., Whorwell, P. J., & de Wit, N. J. (2019). Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): A multicentre randomised controlled trial. The Lancet Gastroenterology & Hepatology, 4(1), 20–31. https://doi.org/10.1016/S2468-1253(18)30310-8
   PubMed Web of Science ®Google Scholar
• Fuller-Thomson, E., & Sulman, J. (2006). Depression and inflammatory bowel disease: Findings from two nationally representative Canadian surveys. Inflammatory Bowel Diseases, 12(8), 697–707. https://doi.org/10.1097/00054725-200608000-00005
   PubMed Web of Science ®Google Scholar
• Gonsalkorale, W. M. Miller, V., Afzal, A, & Whorwell, P. J. (2003). Long term benefits of hypnotherapy for irritable bowel syndrome. Gut, 52(11), 1623–1629. https://doi.org/10.1136/gut.52.11.1623
   PubMed Web of Science ®Google Scholar
• Hoekman, D. R., Vlieger, A. M., Stokkers, P. C., Mahhmod, N., Rietdijk, S., de Boer, N. K., de Meij, T. G., Frankenhuis, C., D’Haens, G. R., & Benninga, M. A. (2021). Hypnotherapy for irritable bowel syndrome-type symptoms in patients with quiescent inflammatory bowel disease: A randomized, controlled trial. Journal of Crohn’s and Colitis, 15(7), 1106–1113. https://doi.org/10.1093/ecco-jcc/jjaa241
   PubMed Web of Science ®Google Scholar
• Hu, S., Chen, Y., Chen, Y., & Wang, C. (2021). Depression and anxiety disorders in patients with inflammatory bowel disease. Frontiers in Psychiatry, 12, 714057. https://doi.org/10.3389/fpsyt.2021.714057
   PubMed Web of Science ®Google Scholar
• Jelsness-Jørgensen, L. P., Bernklev, T., & Moum, B. (2013). Calprotectin is a useful tool in distinguishing coexisting irritable bowel-like symptoms from that of occult inflammation among inflammatory bowel disease patients in remission. Gastroenterology Research and Practice, 2013, 620707. https://doi.org/10.1155/2013/620707
   PubMed Web of Science ®Google Scholar
• Keefer, L., Kiebles, J. L., Kwiatek, M. A., Palsson, O., Taft, T. H., Martinovich, Z., & Barrett, T. A. (2012). The potential role of a self-management intervention for ulcerative colitis: A brief report from the ulcerative colitis hypnotherapy trial. Biological Research for Nursing, 14(1), 71–77. https://doi.org/10.1177/1099800410397629
   PubMed Web of Science ®Google Scholar
• Keefer, L., Taft, T. H., Kiebles, J. L., Martinovich, Z., Barrett, T. A., & Palsson, O. S. (2013). Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Alimentary Pharmacology & Therapeutics, 38(7), 761–771. https://doi.org/10.1111/apt.12449
   PubMed Web of Science ®Google Scholar
• Keohane, J., O’Mahony, C., O’Mahony, L., O’Mahony, S., Quigley, E. M., & Shanahan, F. (2010). Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: A real association or reflection of occult inflammation? The American Journal of Gastroenterology, 105(8), 1788–1795. https://doi.org/10.1038/ajg.2010.156
   PubMed Web of Science ®Google Scholar
• Kvarnström, K., Westerholm, A., Airaksinen, M., & Liira, H. (2021). Factors contributing to medication adherence in patients with a chronic condition: A scoping review of qualitative research. Pharmaceutics, 13(7), 1100. https://doi.org/10.3390/pharmaceutics13071100
   PubMed Web of Science ®Google Scholar
• Lamers, C. R., de Roos, N. M., Heerink, H. H., van de Worp-Kalter, L. A., & Witteman, B. J. M. (2022). Lower impact of disease on daily life and less fatigue in patients with inflammatory bowel disease following a lifestyle intervention. Inflammatory Bowel Diseases, 28(12), 1791–1799. https://doi.org/10.1093/ibd/izac027
   PubMed Web of Science ®Google Scholar
• Laredo, V., García-Mateo, S., Martínez-Domínguez, S. J., López de la Cruz, J., Gargallo-Puyuelo, C. J., & Gomollón, F. (2023). Risk of cancer in patients with inflammatory bowel diseases and keys for patient management. Cancers, 15(3), 871. https://doi.org/10.3390/cancers15030871
   PubMed Web of Science ®Google Scholar
• Lee, A., Moulton, D., Mckernan, L., Russell, A., Slaughter, J. C., Acra, S., & Walker, L. (2021). Clinical hypnosis in pediatric crohn’s disease: A randomized controlled pilot study. Journal of Pediatric Gastroenterology and Nutrition, 72(3), e63–e70. https://doi.org/10.1097/MPG.0000000000002980
   PubMed Web of Science ®Google Scholar
• Lee, M., & Chang, E. B. (2021). Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues. Adenocarcin Barrett’s Epithelium Gastroenterol, 160(2), 524–537. https://doi.org/10.1053/j.gastro.2020.09.056
   PubMed Web of Science ®Google Scholar
• Lindfors, P., Unge, P., Nyhlin, H., Ljótsson, B., Björnsson, E. S., Abrahamsson, H., & Simrén, M. (2012). Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome. Scandinavian Journal of Gastroenterology, 47(4), 414–420. https://doi.org/10.3109/00365521.2012.658858
   PubMed Web of Science ®Google Scholar
• Lores, T., Evans, S., Chur-Hansen, A., Andrews, J. M., Goess, C., Smith, L., Skvarc, D., & Mikocka-Walus, A. A. (2023). Virtual adjunctive gut-directed hypnotherapy for people with Crohn’s disease: A randomized controlled pilot and feasibility trial. Complementary Therapies in Clinical Practice, 53, 101791. https://doi.org/10.1016/j.ctcp.2023.101791
   PubMed Web of Science ®Google Scholar
• Mawdsley, J. E., Jenkins, D. G., Macey, M. G., Langmead, L., & Rampton, D. S. (2008). The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. The American Journal of Gastroenterology, 103(6), 1460–1469. https://doi.org/10.1111/j.1572-0241.2008.01845.x
   PubMed Web of Science ®Google Scholar
• Miller, V., & Whorwell, P. J. (2008). Treatment of inflammatory bowel disease: A role for hypnotherapy? The International Journal of Clinical and Experimental Hypnosis, 56(3), 306–317. https://doi.org/10.1080/00207140802041884
   PubMed Web of Science ®Google Scholar
• Moser, G., Trägner, S., Gajowniczek, E. E., Mikulits, A., Michalski, M., Kazemi-Shirazi, L., Kulnigg-Dabsch, S., Führer, M., Ponocny-Seliger, E., Dejaco, C., & Miehsler, W. (2013). Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: A randomized controlled trial. The American Journal of Gastroenterology, 108(4), 602–609. https://doi.org/10.1038/ajg.2013.19
   PubMed Web of Science ®Google Scholar
• Munkholm, P., Loftus, E. V., Jr., Reinacher-Schick, A., Kornbluth, A., Mittmann, U., & Esendal, B. (2006). Prevention of colorectal cancer in inflammatory bowel disease: Value of screening and 5-aminosalicylates. Digestion, 73(1), 11–19. https://doi.org/10.1159/000090763
   PubMed Web of Science ®Google Scholar
• Muzammil, M. A., Fariha, F., Patel, T., Sohail, R., Kumar, M., Khan, E., Khanam, B., Kumar, S., Khatri, M., Varrassi, G., & Vanga, P. (2023). Advancements in inflammatory bowel disease: A narrative review of diagnostics, management, epidemiology, prevalence, patient outcomes, quality of life, and clinical presentation. Cureus, 15(6), e41120. https://doi.org/10.7759/cureus.41120
   PubMed Web of Science ®Google Scholar
• Palsson, O. S. (2015). Hypnosis treatment of gastrointestinal disorders: A comprehensive review of the empirical evidence. The American Journal of Clinical Hypnosis, 58(2), 134–158. https://doi.org/10.1080/00029157.2015.1039114
   PubMed Web of Science ®Google Scholar
• Peters, S. L., Muir, J. G., & Gibson, P. R. (2015). Review article: Gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 41(11), 1104–1115. https://doi.org/10.1111/apt.13202
   PubMed Web of Science ®Google Scholar
• Rampton, D. S., Emmanuel, A., Langmead, L., & Sanderson, J. D. (2007). Hypnotherapy for prevention of relapse in ulcerative colitis: A randomised, single-blind. Controlled clinical trial. https://clinicaltrials.gov/study/NCT00553163
   Google Scholar
• Singh, U. P., Singh, N. P., Busbee, B., Guan, H., Singh, B., Price, R. L., Taub, D. D., Mishra, M. K., Nagarkatti, M., & Nagarkatti, P. S. (2012). Alternative medicines as emerging therapies for inflammatory bowel diseases. International Reviews of Immunology, 31(1), 66–84. https://doi.org/10.3109/08830185.2011.642909
   PubMed Web of Science ®Google Scholar
• Smith, S. M., & Vale, W. W. (2006). The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues in Clinical Neuroscience, 8(4), 383–395. https://doi.org/10.31887/DCNS.2006.8.4/ssmith
   PubMedGoogle Scholar
• Tillisch, K. (2006). Complementary and alternative medicine for functional gastrointestinal disorders. Gut, 55(5), 593–596. https://doi.org/10.1136/gut.2005.078089
   PubMed Web of Science ®Google Scholar
• Walker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L., Rawsthorne, P., Miller, N., Rogala, L., McPhail, C. M., & Bernstein, C. N. (2008). The Manitoba IBD cohort study: A population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. The American Journal of Gastroenterology, 103(8), 1989–1997. https://doi.org/10.1111/j.1572-0241.2008.01980.x
   PubMed Web of Science ®Google Scholar
• Williamson, A. (2019). What is hypnosis and how might it work? Palliative Care, 12, 1178224219826581. https://doi.org/10.1177/1178224219826581
   Google Scholar
• Zhao, L. N., Li, J. Y., Yu, T., Chen, G. C., Yuan, Y. H., Chen, Q. K., & Cominelli, F. (2014). 5-aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: An updated meta-analysis. PLOS ONE, 9(4), e94208. https://doi.org/10.1371/journal.pone.0094208
   PubMed Web of Science ®Google Scholar